About Accel Diagnostics
Accel Diagnostics is a company based in Pittsburgh (United States) founded in 2012. Accel Diagnostics has raised $950 thousand across 4 funding rounds from investors including Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University and AlphaLab. Accel Diagnostics offers products and services including COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests. Accel Diagnostics operates in a competitive market with competitors including ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$950 K (USD)
in 4 rounds
-
Latest Funding Round
$200 K (USD), Seed
Apr 25, 2013
-
Investors
Innovation Works
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accel Diagnostics
Accel Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests.
Provides RT-PCR and antigen tests for COVID-19 detection and travel needs.
Offers panels for detecting various substances in urine samples.
Includes annual check-ups for liver, kidney, and thyroid functions.
Detects common sexually transmitted infections for early treatment.
Covers blood counts, lipid panels, and hormone tests for overall health.
Funding Insights of Accel Diagnostics
Accel Diagnostics has successfully raised a total of $950K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accel Diagnostics
Accel Diagnostics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University and AlphaLab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Accelerator programs supporting startups in technology sectors, including software and robotics, in Pittsburgh.
|
Locked | Locked | Locked | |
|
Software, hardware, and life sciences startups are funded and accelerated.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Accel Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accel Diagnostics
Investment portfolio details for Accel Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accel Diagnostics
Detailed financials for Accel Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accel Diagnostics Comparisons
Peer comparison for Accel Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accel Diagnostics
Accel Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microfluidic technology and solutions are provided for life sciences industries.
|
|
| Locked | Locked | Locked |
Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI
|
|
| Locked | Locked | Locked |
Microgravity research solutions are provided for researchers and companies.
|
|
| Locked | Locked | Locked |
Microfluidic devices and lab-on-chip solutions are designed and manufactured.
|
|
| Locked | Locked | Locked |
Point-of-care instruments for diagnostics and research are developed.
|
|
| Locked | Locked | Locked |
Microfluidics and microtechnology solutions are developed for drug permeability testing.
|
Detailed competitors of Accel Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accel Diagnostics
Complete news archive for Accel Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accel Diagnostics
Accel Diagnostics was founded in 2012.
Accel Diagnostics is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Accel Diagnostics is a funded company, having raised a total of $950K across 4 funding rounds to date.
Accel Diagnostics (AccelDx) is a medical technology company. Its product pScreen is a finger-prick blood test for the diagnosis, monitoring and management of a wide variety of diseases and medical conditions, including heart failure, cancer, womens health and infectious diseases. Users apply a small drop of body fluid (e.g., finger prick blood, urine) onto the pScreen. In less than 20 minutes, pScreen allows them to monitor and track the level of proteins (biomarkers) that map the health risk of the patient. It enables patients to monitor and effectively manage the progression of their chronic diseases. Users can scan the pScreen card with their smartphone to communicate the results to their healthcare provider.
Accel Diagnostics's top competitors include Noul, Suzhou Akso Biotechnology and Axbio.
Accel Diagnostics offers COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests.
Accel Diagnostics has 3 investors. Key investors include Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University, and AlphaLab.